What is it about?
This paper shows the rapid rebounce of the myopic refractive error after cessation of 1% atropine eyedrops.
Featured Image
Why is it important?
Myopia is very common in school children, and atropine eyedrop is the only pharmacologically proven therapy to date.
Perspectives
A lower concentration of atropine should be considered to avoid the rapid rebounce phenomenon.
Prof Louis Tong
National University of Singapore
Read the Original
This page is a summary of: Atropine for the Treatment of Childhood Myopia: Effect on Myopia Progression after Cessation of Atropine, Ophthalmology, March 2009, Elsevier,
DOI: 10.1016/j.ophtha.2008.10.020.
You can read the full text:
Contributors
The following have contributed to this page
